Teva Gets Judge To Nix Drug IP Inventorship Correction Order

Law360 (June 10, 2021, 8:19 PM EDT) -- A New Jersey federal judge took the unusual step of reversing an order telling the U.S. Patent and Trademark Office to add two inventors to a Janssen Pharmaceuticals Inc. patent after its rival Teva informed the court that it had never consented to the inventors' addition.

In an order Wednesday, U.S. Magistrate Judge Leda D. Wettre vacated a June 3 order granting Janssen's motion to correct the inventorship of a patent on its schizophrenia drug Invega Sustenna, which it has accused Teva Pharmaceuticals USA Inc. of infringing with its planned generic. Judge Wettre said she had only granted the motion because...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!